Innovation
2 patent families — focus: Human necessities; filing pace accelerating. Cited 14 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Social engagement
Social engagement: 4.3K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
5 investors on record; lead investors include Andreessen Horowitz, NFX, LionBird, Base4 Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Other / undisclosed | 1 | 20% |
Recent activity
17 Jun 2026
Partnership
Blue Marlin Therapeutics
8 Jun 2026
Partnership
Inceptive
6 May 2026
Event
American Society of Gene & Cell Therapy conference ASGCT2026